Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Peripapillary Blood Flow After Use of Anti-glaucoma Medications: A Prospective, Quantitative OCT Angiography Study

NCT03323164 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.

NCT NCT03323164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Peripapillary Blood Flow After Use of Anti-glaucoma Medications: A Prospective, Quantitative OCT Angiography Study
Lead sponsor
Wills Eye
Phase
Phase 4
Overall status
Completed
Start date
July 10, 2017
Completion date
May 30, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma; drugs, normal tension glaucoma, primary open-angle glaucoma